buflomedil has been researched along with cilostazol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Landi, A | 1 |
Dobesh, PP; Persson, EL; Stacy, ZA | 1 |
2 review(s) available for buflomedil and cilostazol
Article | Year |
---|---|
[Secondary prevention and conservative therapy of obliterative arteriosclerosis].
Topics: Arteriosclerosis Obliterans; Cilostazol; Clinical Trials as Topic; Epoprostenol; Exercise; Hematologic Agents; Hemodilution; Hemorheology; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Intermittent Claudication; Nafronyl; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrrolidines; Risk Factors; Smoking; Tetrazoles; Vasodilator Agents; Walking | 2004 |
Pharmacologic therapy for intermittent claudication.
Topics: Cilostazol; Clinical Trials as Topic; Dietary Supplements; Drugs, Investigational; Exercise Therapy; Guidelines as Topic; Humans; Intermittent Claudication; Meta-Analysis as Topic; Nafronyl; Pentoxifylline; Peripheral Vascular Diseases; Pyrrolidines; Risk Factors; Tetrazoles; Treatment Outcome | 2009 |